236 related articles for article (PubMed ID: 29605824)
21. Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm Infants.
Mithal LB; Palac HL; Yogev R; Ernst LM; Mestan KK
PLoS One; 2017; 12(1):e0168677. PubMed ID: 28045978
[TBL] [Abstract][Full Text] [Related]
22. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the S100 protein A12 as a biomarker of neonatal sepsis.
Tosson AMS; Glaser K; Weinhage T; Foell D; Aboualam MS; Edris AA; El Ansary M; Lotfy S; Speer CP
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2768-2774. PubMed ID: 30563403
[No Abstract] [Full Text] [Related]
24. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis.
Adly AA; Ismail EA; Andrawes NG; El-Saadany MA
Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866
[TBL] [Abstract][Full Text] [Related]
25. Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis.
Badr HS; El-Gendy FM; Helwa MA
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2209-2215. PubMed ID: 28562124
[TBL] [Abstract][Full Text] [Related]
26. Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants.
Halil H; Tayman C; Buyuktiryaki M; Okur N; Cakır U; Serkant U
Comb Chem High Throughput Screen; 2018; 21(7):510-515. PubMed ID: 30207217
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 as a Biomarker of Early-Onset Neonatal Sepsis.
Cortés JS; Losada PX; Fernández LX; Beltrán E; DeLaura I; Narváez CF; Fonseca-Becerra CE
Am J Perinatol; 2021 Aug; 38(S 01):e338-e346. PubMed ID: 32446256
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants.
Cetinkaya M; Ozkan H; Köksal N; Celebi S; Hacimustafaoğlu M
J Perinatol; 2009 Mar; 29(3):225-31. PubMed ID: 19078972
[TBL] [Abstract][Full Text] [Related]
29. Bilirubin exposure is associated with neonatal sepsis in the eight days preceding symptoms: a retrospective study.
Raimondi F; Borrelli AC; Ferrara T; Giannattasio A; Capasso L
J Matern Fetal Neonatal Med; 2017 Sep; 30(17):2078-2080. PubMed ID: 27633519
[TBL] [Abstract][Full Text] [Related]
30. Higher blood urea nitrogen level is independently linked with the presence and severity of neonatal sepsis.
Li X; Li T; Wang J; Dong G; Zhang M; Xu Z; Hu Y; Xie B; Yang J; Wang Y
Ann Med; 2021 Dec; 53(1):2192-2198. PubMed ID: 34783614
[TBL] [Abstract][Full Text] [Related]
31. Utility of cytokines to predict neonatal sepsis.
Ye Q; Du LZ; Shao WX; Shang SQ
Pediatr Res; 2017 Apr; 81(4):616-621. PubMed ID: 27997530
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis.
Shi J; Tang J; Chen D
Ital J Pediatr; 2016 Jun; 42(1):57. PubMed ID: 27268050
[TBL] [Abstract][Full Text] [Related]
33. Pentraxin 3 as a novel diagnostic marker in neonatal sepsis.
Fahmey SS; Mostafa N
J Neonatal Perinatal Med; 2019; 12(4):437-442. PubMed ID: 31381534
[TBL] [Abstract][Full Text] [Related]
34. Clinical Value of Serum Amyloid-A Protein, High-density Lipoprotein Cholesterol and Apolipoprotein-A1 in the Diagnosis and Follow-up of Neonatal Sepsis.
Bourika V; Hantzi E; Michos A; Margeli A; Papassotiriou I; Siahanidou T
Pediatr Infect Dis J; 2020 Aug; 39(8):749-755. PubMed ID: 32251257
[TBL] [Abstract][Full Text] [Related]
35. Can resistin be a new indicator of neonatal sepsis?
Aliefendioglu D; Gürsoy T; Çağlayan O; Aktaş A; Ovalı F
Pediatr Neonatol; 2014 Feb; 55(1):53-7. PubMed ID: 23820264
[TBL] [Abstract][Full Text] [Related]
36. Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis.
Tunç T; Polat A; Özdemir R; Kiliçaslan B; Can E; Çelik HT; Arsan S; Kader Ş; Erol S; Uslu S; Özdemir ÖMA; ; Özcan B; Hanta D; Dilli D; Narter F; Gültekin N; Güzoğlu N; Aydemir Ö
J Neonatal Perinatal Med; 2020; 13(1):47-54. PubMed ID: 31594258
[TBL] [Abstract][Full Text] [Related]
37. Can melatonin be used as a marker for neonatal sepsis?
El-Mashad AR; Elmahdy H; El-Dib M; Elbatch M; Aly H
J Matern Fetal Neonatal Med; 2016 Sep; 29(17):2870-3. PubMed ID: 26471842
[TBL] [Abstract][Full Text] [Related]
38. The usefulness of C-reactive protein as a biomarker in predicting neonatal sepsis in a sub-Saharan African region.
Bunduki GK; Adu-Sarkodie Y
BMC Res Notes; 2020 Apr; 13(1):194. PubMed ID: 32238170
[TBL] [Abstract][Full Text] [Related]
39. Paraoxonase (PON)-1 activity in septic neonates: One more arrow in the quiver of biomarkers of neonatal sepsis?
Bourika V; Bartzeliotou A; Spiliopoulou C; Michos A; Papassotiriou I; Siahanidou T
Clin Biochem; 2021 Jul; 93():119-121. PubMed ID: 33831384
[TBL] [Abstract][Full Text] [Related]
40. Red cell distribution width and its association with mortality in neonatal sepsis.
Martin SL; Desai S; Nanavati R; Colah RB; Ghosh K; Mukherjee MB
J Matern Fetal Neonatal Med; 2019 Jun; 32(12):1925-1930. PubMed ID: 29310472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
